- Erice A, Chou S, Biron KK, Stanat SC, Balfour HH, Jordan MC. Progressive disease due to ganciclovir-resistant cytomegalovirus in immunocompromised patients. N Engl J Med 1989; 320: 289–93.
- Drew WL, Miner RC, Busch DF, Follansbee SE, Gullett J, Mehalko SG, et al. Prevalence of resistance in patients receiving ganciclovir for serious CMV infection. J Infect Dis 1991; 163: 716–9.
- Erice A, Gil-Roda C, Pérez JL, Balfour HH, Sannerud KJ, Hanson MN, et al. Antiviral susceptibilities and analysis of UL97 and DNA polymerase sequences of clinical cytomegalovirus isolates from immunocompromised patients. J Infect Dis 1997; 175: 1087–92.
- Chou S, Erice A, Jordan C, Vercellotti GM, Michels KR, Talarico CL, et al. Analysis of the UL97 phosphotransferase coding sequence in clinical cytomegalovirus isolates and identification of mutations conferring ganciclovir resistance. J Infect Dis 1995; 171: 576–83.
- Chou S, Guentzel S, Michels KR, Miner RC, Drew WL. Frequency of UL97 phosphotransferase mutations related to ganciclovir resistance in clinical cytomegalovirus isolates. J Infect Dis 1995; 172: 239–42.
- Baldanti F, Silini E, Sarasini A, Talarico CL, Stanat CS, Biron KK, et al. A three-nucleotide deletion in the UL97 open reading frame is responsible for the ganciclovir resistance of a human cytomegalovirus clinical isolate. J Virol 1995; 69: 796– 800.
- Smith IL, Cherrington JM, Jiles RE, Jiles RE, Fuller MD, Freeman WR, et al. High-level resistance of cytomegalovirus to ganciclovir is associated with alterations in both the UL97 and DNA polymerase genes. J Infect Dis 1997; 176: 69–77.
- Chou S, Marousek G, Guentzel S, Follansbee SE, Poscher ME, Lalezari JP, et al. Evolution of mutations conferring multidrug resistance during prophylaxis and therapy for cytomegalovirus disease. J Infect Dis 1997; 176: 786–9.
- Fries BC, Chou S, Boeckh M, Torok-Storb B. Frequency distribution of cytomegalovirus envelope glycoprotein genotypes in bone marrow transplant recipients. J Infect Dis 1994; 169: 769–74.
- Rasmussen L, Hong C, Zipeto D, Morris S, Sherman D, Chou S, et al. Cytomegalovirus gB genotype distribution differs in human immunodeficiency virus-infected patients and immunocompromised allograft recipients. J Infect Dis 1997; 175: 179– 84.
- Shepp DH, Match ME, Ashraf AB, Lipson SM, Millan C, Pergolizzi R. Cytomegalovirus glycoprotein B groups associated with retinitis in AIDS. J Infect Dis 1996; 174: 184–7.
- Delfau MH, Kerckaert JP, D’Hooge MC, Collyn d’Hooghe M, Fenaux P, Lai JL, et al. Detection of minimal residual disease in chronic myeloid leukemia patients after bone marrow transplantation by polymerase chain reaction. Leukemia 1990; 4: 1–5.
- Chou S. Differentiation of cytomegalovirus strains by restriction analysis of DNA sequences amplified from clinical specimens. J Infect Dis 1990; 162: 738–42.
- Erice A, Borrel N, Li W, Miller WJ, Balfour HH. Ganciclovir susceptibilities and analysis of UL97 region in cytomegalovirus isolates from bone marrow recipients with CMV disease after antiviral prophylaxis. J Infect Dis 1998; 178: 531–4.
- Wolf DG, Lee DJ, Spector SA. Detection of human cytomegalovirus mutations associated with ganciclovir resistance in cerebrospinal fluid of AIDS patients with central nervous system disease. Antimicrob Agents Chemother 1995; 39: 2552–4.
- Wolf DG, Smith IL, Lee DJ, Freeman WR, Flores-Aguilar M. Spector SA. Mutations in human cytomegalovirus UL97 gene confer clinical resistance to ganciclovir and can be detected directly in patient plasma. J Clin Invest 1995; 95: 257–63.
- Erice A. Resistance of human cytomegalovirus to antiviral drugs. Clin Microbiol Rev 1999; 12: 286–97.
- Leach CT, Detels R, Hennessey K, Liu Z, Visscher BR, Dudley JP, et al. A longitudinal study of cytomegalovirus infection in human immunodeficiency virus type 1-seropositive homosexual men: molecular epidemiology and association with disease progression. J Infect Dis 1994; 170: 293–8.
- Drew WL, Miner R, Saleh E. Antiviral susceptibility testing of cytomegalovirus: criteria for detecting resistance to antivirals. Clin Diag Virol 1993; 1: 179.
- Jabs DA, Enger C, Dunn JP, Forman M. Cytomegalovirus retinitis and viral resistance: ganciclovir resistance. J Infect Dis 1998; 177: 770–3.
- Smith IL, Shinkai M, Freeman WR, Spector SA. Polyradiculopathy associated with ganciclovir-resistant cytomegalovirus in an AIDS patient: phenotypic and genotypic characterization of sequential virus isolates. J Infect Dis 1996; 173: 1481–4.
- Smith IL, Taskintuna I, Rahhal FM, Powell HC, Ai E, Mueller AJ, et al. Clinical failure of CMV retinitis with intravitreal cidofovir is associated with antiviral resistance. Arch Ophthalmol 1998; 116: 178–85.
- Boivin G, Chou S, Quirk MR, Erice A, Jordan MC. Detection of ganciclovir resistance mutations and quantitation of cytomegalovirus (CMV) DNA in leukocytes of patients with fatal disseminated CMV disease. J Infect Dis 1996; 173: 523–8.
- Gilbert C, Handfield J, Toma E, Lalonde R, Bergeron MG, Boivin G. Emergence and prevalence of cytomegalovirus mutations associated with ganciclovir resistance in AIDS patients. AIDS 1998; 12: 125–9.
- Hanson MN, Preheim LC, Chou S, Talarico CL, Biron KK, Erice A. Novel mutation in the UL97 gene of a clinical cytomegalovirus strain conferring resistance to ganciclovir. Antimicrob Agents Chemother 1995; 39: 1204–5.
- Alain S, Honderlick P, Grenet D, Stern M, Vadam C, Sanson-Le Pors M, et al. Failure of ganciclovir treatment associated with selection of a ganciclovir-resistant cytomegalovirus strain in a lung transplant recipient. Transplantation. 1997; 63: 1533–6.
- Lurain NS, Ammons HC, Kapell KS, Yeldanti VV, Garrity ER, O’Keefe JP. Molecular analysis of human cytomegalovirus strains from two lung transplant recipients with the same donor. Transplantation 1996; 62: 497–502.
- Harada K, Eizuru Y, Isashiki Y, Ihara S, Minamishima Y. Genetic analysis of a clinical isolate of human cytomegalovirus exhibiting resistance against both ganciclovir and cidofovir. Arch Virol 1997; 142: 215–25.
Scandinavian Journal of Infectious Diseases
Volume 31, 1999 - Issue 6